| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/10/2004 | US6774209 Synthetic, isolated polypeptides overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon; for imaging |
| 08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
| 08/10/2004 | US6774131 Prostate cancer |
| 08/10/2004 | US6774127 Pyrazole and pyrazoline substituted compounds |
| 08/10/2004 | US6774122 Sustained release; injection of fulvestrant |
| 08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
| 08/10/2004 | US6774119 Herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells |
| 08/10/2004 | US6774118 Therapeutic use of CIS-element decoys in vivo |
| 08/10/2004 | US6774117 MN gene and protein |
| 08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
| 08/10/2004 | US6774106 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3 and TACI |
| 08/10/2004 | US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments) |
| 08/10/2004 | US6773715 Preparation and use of solidified oils |
| 08/10/2004 | US6773714 Polymeric delivery formulations of leuprolide with improved efficacy |
| 08/10/2004 | US6773709 Chicken embryo lethal (CELO) virus |
| 08/10/2004 | US6773701 Expression enhancer for protein synthesis inhibitory genes |
| 08/10/2004 | CA2255661C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 08/10/2004 | CA2187024C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 08/10/2004 | CA2121041C Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 08/09/2004 | CA2538147A1 Farnesyl dibenzodiazepinone, processes for its production and its use as a pharmaceutical |
| 08/05/2004 | WO2004065960A1 Novel screening method |
| 08/05/2004 | WO2004065607A1 Novel physiologically active substance rs-k3574 and process for producing the same |
| 08/05/2004 | WO2004065590A2 Activation and expansion of t cells |
| 08/05/2004 | WO2004065572A2 Proteic binding partners of tctp and methods of modulating tumor reversion or cell apoptosis |
| 08/05/2004 | WO2004065422A2 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065421A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065420A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065419A1 Antibody and use thereof |
| 08/05/2004 | WO2004065400A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 08/05/2004 | WO2004065391A1 4-AMINOTHIENO[2,3-d]PYRIMIDINE-6-CARBONITRILE DERIVATIVES AS PDE7 INHIBITORS |
| 08/05/2004 | WO2004065381A1 Process for making ondansetron and intermediates thereof |
| 08/05/2004 | WO2004065354A1 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 08/05/2004 | WO2004065349A1 Medically useful 1-phenyl-2-aminomethyl naphthalenes, method for producing them, drugs containing them and use thereof |
| 08/05/2004 | WO2004064868A1 Tarp promoter and uses thereof |
| 08/05/2004 | WO2004064857A1 Drugs containing galectin 9 |
| 08/05/2004 | WO2004064855A1 Medicament and use thereof for tumor therapy |
| 08/05/2004 | WO2004064826A1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 08/05/2004 | WO2004064824A1 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments |
| 08/05/2004 | WO2004064822A1 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064743A2 Modified retinoid compounds and their uses |
| 08/05/2004 | WO2004064715A2 Polyhydroxylated pyrrolizidine |
| 08/05/2004 | WO2004064543A1 Compositions containing coenzyme q10 |
| 08/05/2004 | WO2004043389A3 Methods of treating cancer and related methods |
| 08/05/2004 | WO2004041307A3 Compositions and methods for treating cancer using cytotoxic cd44 antibody immunoconjugates and radiotherapy |
| 08/05/2004 | WO2004026867A3 Imidazopyridines as cyclin dependent kinase inhibitors |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004012746A3 New uses for inhibitors of inosine monophosphate dehydrogenase |
| 08/05/2004 | WO2004011456A8 Protein tyrosine kinase inhibitors |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003077874A3 Substituted tetrahydroisoquinoline compounds, methods of making, and their use |
| 08/05/2004 | WO2003068144A3 Cytotoxic agents |
| 08/05/2004 | WO2003048729A3 Discovery of therapeutic products |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | WO2003000187A3 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof |
| 08/05/2004 | WO2002102976A3 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/05/2004 | WO2002101357A3 Molecular signatures of commonly fatal carcinomas |
| 08/05/2004 | WO2002066435B1 Metal complexes and therapeutic uses thereof |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | US20040152897 Synthesis of indolizines |
| 08/05/2004 | US20040152892 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152772 1-butyric acid derivatives and the use thereof |
| 08/05/2004 | US20040152766 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152760 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152744 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; antichoilesterol agents; cardiovascular disorders |
| 08/05/2004 | US20040152735 NO-synthase inhibitors comprising N,N'-bis(2-pyridyl)methyl-N,N'-bis(3,4,5-trimethoxybenzyl) ethylenediamine |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152723 Pharmaceutical compositions and methods for use |
| 08/05/2004 | US20040152721 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 08/05/2004 | US20040152717 Urogenital disorders; bleeding; hormone replacement therapy; anticancer agents; contraceptives |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152691 Antiproliferative agents |
| 08/05/2004 | US20040152687 Having anticancer and antitumor effects; porphyrin moiety selectively localizes in tumors, while the polyamine moiety serves as a cytotoxic agent |
| 08/05/2004 | US20040152686 Metal complexes and therapeutic uses thereof |
| 08/05/2004 | US20040152685 Agents and methods for the prevention of initial onset and recurrence of existing cancers |
| 08/05/2004 | US20040152681 Interact with nuclear liver X receptor (LXR) and ubiquitous receptor (UR) and can be used to treat a variety of LXR- or UR-mediated disorders |
| 08/05/2004 | US20040152680 Treating autoimmune diseases, skin disorders, malignancies |
| 08/05/2004 | US20040152679 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152678 Administering 20S)-1 alpha -hydroxy-2 alpha -methyl-19-nor-vitamin D3 for therapy of psoriasis |
| 08/05/2004 | US20040152677 (20S)-1alpha-hydroxy-2alpha-methl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152676 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152675 (20S)-1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 08/05/2004 | US20040152673 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152672 Indole compounds useful for the treatment of cancer |
| 08/05/2004 | US20040152668 Vitamin d receptor antagonists and related compositions and methods of use |
| 08/05/2004 | US20040152655 Antisense oligonucleotides that inhibit expression of HIF-1 |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152644 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152643 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152642 For therapy of of neoplastic diseases |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152630 14-3-3 Binding molecules as sensitizers for anticancer therapies |
| 08/05/2004 | US20040152629 For use as anticancer compounds and prodrugs |
| 08/05/2004 | US20040152191 Using activator glycoprotein to propagate activated macrophages or dendritic cells from monocytes or hematopoietic stem cells for use in treatment of allergic, cell proliferative, autoimmune and infectious disorders |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |